Saturday, August 2, 2025
News Health
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
HealthNews
No Result
View All Result
Home Health News

Are IV Proton Pump Inhibitors Overused in Upper GI Bleeding?

July 10, 2025
in Health News
Share on FacebookShare on Twitter


TOPLINE:

Nearly 70% of patients with acute upper gastrointestinal (GI) bleeding and low-risk or no peptic ulcer disease received intravenous (IV) proton pump inhibitors (PPIs) inappropriately, leading to longer hospital stays.

METHODOLOGY:

  • Current guidelines recommend transitioning from IV to oral PPIs after esophagogastroduodenoscopy (EGD) if no high-risk stigmata are found and stopping PPIs in patients with upper GI bleeding from causes other than peptic ulcer disease.
  • Researchers conducted a retrospective cohort study of patients hospitalized for acute upper GI bleeding between January 2014 and December 2019.
  • All patients were started on continuous or intermittent IV PPI and underwent EGD that showed a gastric or duodenal ulcer with low-risk signs or lesions unrelated to ulcer disease.
  • Inappropriate use was defined as any continuous IV PPI infusion lasting more than 4 hours after EGD or any intermittent dose administered after the procedure.

TAKEAWAY:

  • Researchers analyzed 253 patients (mean age, 62 years; 57% women; 35% White/Caucasian), of whom only 79 (31%) received appropriate PPI therapy, whereas 174 (69%) received it inappropriately (55 on continuous IV PPI infusion and 119 receiving excess intermittent doses).
  • Patients with peptic ulcer disease with low-risk stigmata received an average of five excess IV PPI doses, and those on continuous infusions received an average of 41 additional hours of treatment.
  • Among patients with lesions unrelated to peptic ulcer disease or with no lesions at all, those receiving twice daily IV PPI dosing averaged six extra doses, and those on continuous infusion received an average of 34 additional hours of therapy.
  • At baseline, hemoglobin levels were slightly lower in the inappropriate therapy group than in the appropriate group (7.9 vs 8.7 g/dL).
  • Patients receiving appropriate therapy had a shorter hospital stay than those receiving inappropriate therapy (4 vs 7 days; P = .001).

IN PRACTICE:

“We believe that educating practitioners on the appropriate use of PPI therapy in the context of the endoscopic lesion that was believed to have caused bleeding is a critically important next step,” the authors wrote.

SOURCE:

This study was led by Michael M. Sutton, MD, University of Oklahoma Health Sciences Center, Oklahoma City. It was published online in the Journal of Clinical Gastroenterology.

LIMITATIONS:

The retrospective design may have introduced biases, such as ascertainment bias, as verbal recommendations for discontinuing IV PPI therapy might not have been documented. The single-center setting limits the generalizability of the findings.

DISCLOSURES:

This study was supported in part by grants from the National Institutes of Health — the National Institute of Diabetes and Digestive and Kidney Disease, the National Institute of General Medical Sciences, and the National Center for Advancing Translational Sciences. The authors reported having no conflicts of interest.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.



Source link : https://www.medscape.com/viewarticle/are-iv-proton-pump-inhibitors-overused-upper-gi-bleeding-2025a1000ib2?src=rss

Author :

Publish date : 2025-07-10 10:47:00

Copyright for syndicated content belongs to the linked Source.

Previous Post

South Africans fear spike in HIV infections as US aid cuts bite

Next Post

What Your Personality Says About the Type of Exercise You Enjoy

Related Posts

Health News

Major Medical Groups Pushed Out of Role Supporting CDC’s Vaccine Advisors

August 1, 2025
Health News

‘It’s Gonna Be (Ly)me’: Justin Timberlake Brings Attention, Awareness to Disease

August 1, 2025
Health News

ACOG No Longer Accepting Federal Funding, Citing Policy Disputes

August 1, 2025
Health News

States Sue Trump, Say Targeting of Hospitals Over Gender Care in Minors Is Unlawful

August 1, 2025
Health News

Time Your Meals, Tune Your Metabolism

August 1, 2025
Health News

Novel Eye Drops for Age-Related Blurry Vision Win FDA Approval

August 1, 2025
Load More

Major Medical Groups Pushed Out of Role Supporting CDC’s Vaccine Advisors

August 1, 2025

‘It’s Gonna Be (Ly)me’: Justin Timberlake Brings Attention, Awareness to Disease

August 1, 2025

ACOG No Longer Accepting Federal Funding, Citing Policy Disputes

August 1, 2025

States Sue Trump, Say Targeting of Hospitals Over Gender Care in Minors Is Unlawful

August 1, 2025

Time Your Meals, Tune Your Metabolism

August 1, 2025

Novel Eye Drops for Age-Related Blurry Vision Win FDA Approval

August 1, 2025

Bone Health in Duchenne Muscular Dystrophy

August 1, 2025

Could we get quantum spookiness even without entanglement?

August 1, 2025
Load More

Categories

Archives

August 2025
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    

© 2022 NewsHealth.

No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health

© 2022 NewsHealth.

Go to mobile version